Comparing treatments for inflammation in patients with eye prostheses
Official title: Comparison of Topical Hydrocortisone Versus Dexamethasone Treatment for Inflammatory Secretions of the Conjonctiva in Patients With Ocular Prostheses
Run by Rennes University Hospital · NCT05668455 · Data updated 2026-11-12
This study is testing whether Hydrocortisone or Dexamethasone can help reduce inflammation and discomfort in people who wear eye prostheses.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Rennes University Hospital Academic / other |
| Locations | 1 site (Rennes) |
| Status | Recruiting |
| Started | May 12, 2023 |
| Main results expected | December 25, 2025 |
| Study ends | July 20, 2026 |
| Registry record updated | August 15, 2025 |
| Trial ID | NCT05668455 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who have been wearing a permanent ocular prosthesis for more than six months and experience significant functional discomfort.
✕Probably not a fit
Patients who have recently used other eye drops or have specific contraindications to the study treatments may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effectiveness of Hydrocortisone and Dexamethasone in treating ocular inflammation in patients who wear ocular prostheses. It will utilize a prospective, placebo-controlled, single-blind design to assess the impact of these anti-inflammatory treatments on patients experiencing significant discomfort. The study builds on previous findings from a pilot study that suggested Dexamethasone may be beneficial, but seeks to provide more rigorous evidence through a controlled methodology.
Why it matters
Potential benefit: If successful, this study could significantly improve the quality of life for patients with ocular prostheses by reducing inflammation and discomfort.
How similar studies have gone: Previous studies have shown some promise with Dexamethasone in similar patient populations, but this study aims to provide more definitive evidence through a controlled approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient aged 18 years or older; * Wearing a permanent prosthesis for more than 6 months; - Consultant in the ophthalmology department; * Modified OSDI score ≥ 20 points out of 40 ; * Affiliated with a health insurance scheme, * For women of childbearing age: effective contraception (effective contraception includes oral contraception, intrauterine devices and other forms of contraception with a failure rate \<1%, for the duration of the study and up to 1 week after the last dose administered) * Have given free, informed and written consent. Exclusion Criteria: * Treatment with eye drop(s) (other than artificial tears or antiseptic) \< 1 month; * Concomitant treatment with CYP3A inhibitors including cobicistat containing drugs, * Known contraindications to study treatments * Dermal fat grafting or complicated cavity; * Gougerot-Sjögren syndrome; * Allergic conjunctivitis; * Damaged prosthesis; * Impossibility of carrying out the various tests required by the protocol for whatever reason (comprehension problems, motor disability); * Pregnant or breastfeeding woman; * Person already included in a RIPH1 research protocol with topical treatment of the cavity or systemic anti-inflammatory treatment and/or who could lead to a bias in the present study * Person under legal protection (safeguard of justice, curatorship, guardianship) or person deprived of liberty.
Where it's running
-
Centre Hospitalier Universitaire de Rennes _ Pontchaillou
Rennes, France Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ear nerve stimulation to help eye inflammation
A small early study will test whether a gentle ear nerve stimulator can reduce eye inflammation in adults with inflammatory eye conditions.
-
Using a dexamethasone insert to manage pain and inflammation after vitreoretinal surgery
This study tests if a new dexamethasone insert can better manage pain and inflammation after eye surgery compared to regular steroid eye drops for adults.
-
See if non-invasive fetal DNA testing after early miscarriage supports mental health and follow-up care
This study tests whether doing non-invasive prenatal testing from a blood sample after an early miscarriage helps with mental well-being and guides care over the next year.
-
Prevalence of PAD in Patients With Surgically Treated Lumbar Spinal Stenosis
This study tests how common peripheral artery disease is in people who have lumbar spinal stenosis and are being considered for, or have had, surgery.
-
Team performance when the lead clinician's vision is temporarily blocked during emergency simulations
This study will test whether temporarily blocking the team leader's vision improves teamwork and non-technical skills during high-fidelity emergency simulations for experienced hospital clinicians.
-
Rivaroxaban for preventing problems in adults with hypertrophic cardiomyopathy and abnormal left atrial strain
This study tests whether rivaroxaban can prevent complications in adults with hypertrophic cardiomyopathy who have abnormal left atrial strain and are in sinus rhythm.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.